What you get by completing this session

  • 35 mins of CPD

    A 25 minute video lecture with presentation slides, you can stop and start anytime you like. 10 minute quiz is included.

  • Certificate of Completion

    Receive a certificate once you complete the session. Download this from your student dashboard or in your course completion email

  • Easy CPD Documentation

    Fill out the CPD Documentation activity at the end of the session, receive a PDF summary of your CPD activity and reflection right to your email inbox to save or print out!

What you'll learn in this expert session

Which immunocompromised patients should be given the recombinant (Shingrix) vs the Inactivated (Zostavax)? Prof Cunningham describes how immunocompromised patients fit into 1 of 3 basic categories. Each of these categories warrants a different degree of caution, and each warrants a different approach to vaccination choice.


About the Expert

Prof Tony Cunningham AO

Prof Anthony (Tony) Cunningham AO, FAHMS, MD, FRACP, FRCPA is an infectious diseases physician, clinical virologist and scientist. He is the past Director, Centre for Virus Research at The Westmead Institute for Medical Research (WIMR); Director, Australian Centre for HIV and Hepatitis Virology Research (ACH2); and Professor in the Faculty of Medicine and Health at the University of Sydney. Prof Cunningham is the lead author of the ‘Vaccines for COVID-19’ paper, commissioned from the Australian Academy of Health and Medical Sciences.

Course curriculum

  • 1

    How to complete this course

    • Instructions
  • 2

    Shingles Vaccination in the Immunocompromised - Which Option for Which Patient?

    • Summary

    • Video lecture (25 mins)

    • Quiz: test your learning (10 mins)
  • 3

    Document your CPD here

    • CPD Documentation and Reflection Activity Tool
  • 4

    Feedback

    • Please let us know your thoughts